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Abstract
Background: Postoperative optic opacification of hydrophilic acrylic intraocular lenses (IOLs) is an uncommon
complication leading to IOL explantation. In the past decade, several studies reported that the granular deposits
responsible for the opacification were probably calcium and phosphate salts; however, the exact mechanism
causing calcification of IOLs is unknown. The aim of this study is to describe clinical and laboratory findings of a
case of late postoperative opacification of an aspheric hydrophilic acrylic IOL (Akreos Adapt AO) after vitrectomy.
Case presentation: A 60-year-old woman diagnosed with cataract and severe nonproliferative diabetic retinopathy
(NPDR) underwent uneventful phacoemulsification and hydrophilic acrylic IOL (Akreos Adapt AO, Bausch & Lomb)
implantation in both eyes. Seven months later, the woman came back with a complaint of blurry vision in the left
eye. Fundus examination revealed vitreous hemorrhage in the left eye veiling the retinal detail. A 23-gauge
vitrectomy with endolaser treatment was performed in the left eye. Ten months after the vitrectomy, the patient
complained of decreased visual acuity in the left eye again. On slit-lamp examination, we observed a well
circumscribed centrally and paracentrally located opacification within the pupillary area localized to the anterior
surface of the IOL. The IOL was explanted from the left eye together with the capsular bag, and an iris-claw lens
(Artisan Aphakia OPHTEC) was implanted. The explanted IOL was examined under pathological evaluation (alizarin
red method).
Conclusions: IOL opacification is a rare event. We described a case of postoperative opacification of the Akreos
Adapt AO IOL after vitrectomy in a patient with proliferative diabetic retinopathy and found the deposits on the
anterior surface of the IOL consisted of calcium aggregates. Given the higher frequency of postoperative
opacification observed in diabetic patients, hydrophilic acrylic IOLs should be used with caution in patients with
diabetes.
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Background
Postoperative optic opacification of hydrophilic acrylic
intraocular lenses (IOLs) is an uncommon complication
leading to IOL explantation. In the past decade, several
studies reported that the granular deposits responsible for
the opacification were probably calcium and phosphate
salts [1–4]; however, the exact mechanism causing
calcification of IOLs is unknown. The aim of this study is
to describe clinical and laboratory findings of a case of late
postoperative opacification of an aspheric hydrophilic
acrylic IOL (Akreos Adapt AO) after vitrectomy.
Case presentation
In February 2014, a 60-year-old woman with type 2 dia-
betes was referred to our hospital. She was diagnosed with
cataract and severe nonproliferative diabetic retinopathy
(NPDR) in both eyes. On examination she had best
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corrected visual acuity (BCVA) 0.02 in the right eye and
0.01 in the left eye. She underwent uneventful phacoemul-
sification and hydrophilic acrylic IOL (Akreos Adapt AO,
Bausch & Lomb) implantation in both eyes. Two weeks
after cataract surgery the BCVA in the left eye improved to
0.4. Then she had fundus fluorescein angiography (FFA)
and received panretinal photocoagulation in both eyes.
In September 2014, the woman came back with com-
plaint of blurry vision in the left eye. Fundus examin-
ation revealed vitreous hemorrhage in the left eye
veiling the retinal detail. We performed a 23-gauge
vitrectomy with endolaser treatment in the left eye.
Ten months after the vitrectomy (July 2015), the patient
complained of decreased visual acuity in the left eye again
(the BCVA was 0.1). On slit-lamp examination, we ob-
served a well circumscribed centrally and paracentrally
located opacification within the pupillary axis localized to
the anterior surface of the IOL (Fig. 1). Scheimpflug
pictures taken by Pentacam (Oculus) showed increased
light scatter on the IOL’s anterior surface (Fig. 2).
The IOL was explanted from the left eye together with
the capsular bag, and an iris-claw lens (Artisan Aphakia
OPHTEC) was implanted (Fig. 3). Three days after the
operation, the BCVA improved to 0.2.
The explanted IOL was sent to research center of
Guangdong Academy of Medical Sciences. The un-
stained IOL was evaluated and photographed under a
light microscope (Olympus Optical Co.,Ltd.). Then the
IOL was rinsed in distilled water, immersed in 1.0 % ali-
zarin red solution (a special stain for calcium) for
10 min, rinsed again in distilled water, and reexamined
under the light microscope.
Light microscopy showed the presence of granular
deposits distributed in an overall round pattern on the
anterior surface of the IOL. The granules were stained
positive for calcium (alizarin red method) (Fig. 4).
Fig. 1 Slit-lamp photographs taken before IOL explantation
Fig. 2 Light scatter was high at the anterior surface of the explanted IOL under Scheimpflug photography, within the area corresponding to the
granular deposits
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Discussion
To date, postoperative opacification of modern hydrophilic
acrylic IOLs has been reported in many cases. The five
major hydrophilic acrylic IOLs include Hydroview (Bausch
& Lomb), the SC60B-OUV (Medical Developmental
Research, Inc.), ACRL-60 (Ophthalmed Inc.), MemoryLens
(Ciba Vision) and AquaSense (Ophthalmic Innovations
International, Inc.) [1–5]. Histopathological analysis and
molecular surface analysis have been performed on the
explanted opacified IOLs, and calcium and phosphate
Fig. 3 Surgical exchange of the opacified Akreos Adapt AO IOL. Opacified IOL explantation together with the capsular bag. An iris-claw lens
was implanted
Fig. 4 Light photomicrographs of the explanted IOL. Unstained photomicrographs showing the deposits on the anterior surface of the explanted
IOL (a, original magnification × 20; b, ×100; c, ×200). The deposits stained positive with alizarin red. (d, original magnification × 20; e, ×100;
f, ×200)
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precipitations were found on the surface/subsurface and/or
within the IOLs.
Akreos adapt AO is a modern aberration-free
aspheric hydrophilic acrylic lens. Only sporadic cases of
optic opacification involving the Akreos adapt AO IOL
have been described (Table 1). In 2008, Shiu Ting Mak
et al. [6] reported the first case of opacification of the
Akreos Adapt AO IOL. The explanted IOL in their case
was examined under scanning electron microscopy, and
foci of calcium and phosphorous were seen in the IOL
material. Liliana Werner et al. [7] described another
two cases of localized opacification of Akreos adapt AO
IOL after procedures using intracameral injection of air
or gas. It was theorized that a metabolic change in the
anterior chamber due to the presence of exogenous gas
in the eye, or an exacerbated inflammatory reaction
after multiple surgical procedures might cause the
calcification of IOL. Later Mattro Forlini et al. [8] and
Chong Eun Lee et al. [5] each outlined a single case de-
veloping optic opacification after glaucoma surgeries
using Akreos adapt AO IOL separately; however, patho-
logic analysis were unavailable in those two cases.
In the present study, the deposits on the explanted IOL
stained positive with alizarin red (a special stain for cal-
cium). The patient had a history of type 2 diabetes for
more than five years. She received phacoemulsification
and was implanted with Akreos adapt AO IOLs in both
eyes; however, only the left eye which presented with vitre-
ous hemorrhage and received vitrectomy developed calci-
fication of the IOL. We presume that preexisting diabetic
retinopathy, inflammatory reaction after vitrectomy or a
breakdown of the blood-aqueous barrier (BAB) may be re-
sponsible for the opacification.
We noticed a higher rate of diabetes in patients with
opacification of Akreos Adapt AO IOLs (four out of
six patients having concomitant diabetes). Previous
studies also supported that IOL opacification was most
common in patients with systemic diseases such as
diabetes [9, 10]. First of all, in cases of diabetic retin-
opathy (DR), where many pathological conditions such
as ischemia/hypoxia, shear stress and inflammation
play a role, intravitreal levels of adenosine triphosphate
(ATP) are significantly increased as compared with
those in non-diabetic controls [11]. Therefore, in-
creased calcium influx is evoked by intravitreal ATP.
Secondly, in the eyes of DR a higher concentration of
intravitreal protein is identified. This is involved in the
production of angiotensin I and elevates the concen-
tration of serum calcium. A combination of the two
hypotheses may lead to the higher incidence of IOL
calcification in diabetic patients. However, we are un-
able to establish a correlation between these complica-
tions and diabetes. Further study is warranted to
continue monitoring cases of hydrophilic acrylic IOL
calcification to verify the percentage of cases associ-
ated with diabetes or DR.
Conclusions
IOL opacification is a rare event. We described a case
of postoperative opacification of Akreos Adapt AO
IOL after vitrectomy in a patient with proliferative
diabetic retinopathy and found the deposits on the
anterior surface of the IOL consisted of calcium aggre-
gates. Given the higher frequency of postoperative
opacification observed in diabetic patients, hydrophilic
acrylic IOLs should be used with caution in patients
with diabetes.
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